Status Epilepticus in the Intensive Care Unit
Adriana Bermeo-Ovalle1, Thomas Bleck2
1Division of Electroencephalography, Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois.
Seminars in Neurology
|December 2, 2016
Summary
Status epilepticus (SE) is a critical neurological emergency. Advances in diagnostics and treatments for SE are improving care, but their impact on patient outcomes requires further research.
Area of Science:
- Neurology
- Critical Care Medicine
Background:
- Status epilepticus (SE) is a frequent neurologic emergency and ICU admission reason.
- Increased recognition of nonconvulsive SE in critically ill patients due to advanced diagnostics.
Purpose of the Study:
- To review the current landscape of SE diagnostics and therapeutics.
- To highlight ongoing research into the application and impact of new SE management strategies.
Main Methods:
- Literature review of recent advancements in SE diagnosis and treatment.
- Analysis of the theoretical basis for early anesthetic intervention in convulsive SE.
Main Results:
- New diagnostic tools have revealed a higher incidence of nonconvulsive SE.
- Novel treatment alternatives for SE have emerged recently.
Conclusions:
- Early anesthetic use in convulsive SE is theorized to mitigate long-term neuronal injury.
- The applicability and impact of new SE diagnostic and treatment tools on patient outcomes remain active research areas.
More Related Videos
Related Concept Videos
01:24Epilepsy and Seizures: Overview
1.6K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
01:13Seizures: Classification
1.9K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.9K
01:30Electroconvulsive Therapy
1.7K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.7K
01:30Acute Respiratory Failure-III
1.0K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.0K
01:20Antiepileptic Drugs: Potassium Channel Activators
880
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
880